Back

France Foundation, The

  • Muscular Dystrophy, Duchenne

Exploring Functional Improvement in the Management of DMD

TARGET AUDIENCE This educational activity is intended for pediatric and adult neurologists, including neuromuscular specialists, who are the primary treaters of patients with DMD; other specialists, such as cardiologists, pulmonologists, and physical therapists, who are part of the multidisciplinary team focusing on shared patient management; and primary care professionals involved in early disease recognition and ongoing care coordination. PROGRAM OVERVIEW This interactive, self-directed EXPLORE eLearning activity is designed to enhance clinicians knowledge and competence in the management of patients with Duchenne muscular dystrophy (DMD). Through chapter-based learning, real-world patient scenarios, expert perspectives, and engaging multimedia, the activity will examine the relationship between dystrophin production and distribution and clinical outcomes; the impact of progressive functional loss and the importance of functional improvement as a treatment goal; and the latest evidence and clinical trial data for current and emerging dystrophin-targeted therapies. Learners will gain practical insights to support informed, patient-centered treatment decisions and optimize care across the DMD disease course. LEARNING OBJECTIVES Upon completion of this activity, learners should be able to: Summarize the impact of dystrophin production and distribution on clinical outcomes for patients with DMD Describe the impact of progressive loss of function in patients with DMD and the importance of functional improvement as a treatment goal Assess the latest evidence and clinical trial results for current and emerging dystrophin-targeted therapies

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 1 credit

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Case-based learning
  • includes Online course / module
  • Credit · Up to 1 credit
  • Commercial Support
  • Released
    Sep 15, 2026
  • Last day to claim credit
    Sep 15, 2027 11 months left